Eosinophilic Fasciitis
Eosinophilic fasciitis, also known as Shulman syndrome, is a rare connective tissue disease marked by inflammation and dense fibrosis of the fascia, the sheet of tissue that wraps around the muscles. An early influx of eosinophils is followed by rapid hardening of the skin, so the arms and legs become thick, stiff and lose their natural elasticity.
At Haute-Derma, we treat this condition as a race against time. Early detection and prompt treatment are key to stopping the fibrosis from spreading and to sparing patients from joint contractures and permanent loss of mobility.
Our Approach to Treating Eosinophilic Fasciitis
Our specialists recognize the condition by its characteristic "orange-peel" skin and restricted limb movement. We confirm the diagnosis with a deep skin biopsy that reaches down to the fascia, so we can accurately judge the degree of inflammation and eosinophilic infiltration.
We know that patients' biggest worry is progressive skin hardening that gets in the way of everyday life. At Haute-Derma, treatment combines potent systemic immunomodulating medication with intensive physical therapy to preserve as much range of motion as possible.
Our comprehensive care pathway includes:
- Full-thickness biopsy including the epidermis, dermis, subcutaneous fat and fascia.
- High-dose corticosteroids combined with maintenance immunosuppressive therapy.
- An individually designed rehabilitation program to prevent joint contractures.
How We Diagnose Eosinophilic Fasciitis at Haute-Derma
Haute-Derma follows a rigorous diagnostic process to distinguish the condition from systemic sclerosis:
- Clinical signs: we look for swelling followed by hardening of the skin on the forearms and lower legs, paying particular attention to the "groove sign": linear depressions along the course of the veins when the arm or leg is raised.
- Skin surface: we check for a dimpled, orange-peel texture (peau d'orange) caused by fibrosis tethering the tissue beneath the skin.
- Blood tests: a marked rise in eosinophils during the acute phase and a raised erythrocyte sedimentation rate (ESR).
- Magnetic resonance imaging (MRI): used to confirm thickening and edema of the fascia before the biopsy is taken.
- Histopathology: evidence of inflamed, thickened fascia containing eosinophils is the single most important diagnostic criterion.
How Is Eosinophilic Fasciitis Treated at Haute-Derma?
Our treatment aims to halt fibrosis and restore flexibility:
- Systemic corticosteroids: our first-line treatment. They are usually started at a high dose to control inflammation quickly, then tapered according to the clinical response.
- Immunosuppressants (methotrexate): often added early to allow lower corticosteroid doses and to prevent relapse.
- Biologic therapy: for treatment-resistant cases, we consider cytokine-targeted drugs that directly suppress eosinophilic inflammation.
- Intensive physical therapy: we start stretching and passive range-of-motion exercises early to prevent joint contractures and muscle wasting.
- Cosmetic care and skin softening: once the inflammation has settled, supportive technologies and specialized products are used to improve skin texture.
